Henry Schein Elects Dr. E. Dianne Rekow To Board Of Directors

        Henry Schein Elects Dr. E. Dianne Rekow To Board Of Directors

Dean of King's College London Dental Institute Brings In-Depth Expertise in
the Fields of Digital Dentistry, Dental Materials and Products, and Dental

PR Newswire

MELVILLE, N.Y., June 3, 2014

MELVILLE, N.Y., June 3, 2014 /PRNewswire/ --Henry Schein, Inc.(NASDAQ:
HSIC), the world's largest provider of health care products and services to
office-based dental, animal health and medical practitioners, announced today
the election of Professor E. Dianne Rekow, D.D.S., Ph.D., to the Company's
Board of Directors. Dr. Rekow, Dean of King's College London Dental Institute
and Professor of Orthodontics, brings to the Henry Schein Board extensive
experience in innovative dental products, practices, and education, as well as
keen insights into global trends influencing the evolution of the dental

Dr. E. Dianne Rekow elected to Henry Schein, Inc. Board of Directors

"In a global dental environment that is quickly evolving through the power of
digital technology, we are very pleased to welcome Dr. Rekow to the Henry
Schein Board of Directors," said Stanley M. Bergman, Chairman of the Board and
Chief Executive Officer of Henry Schein."Dr. Rekow is a recognized pioneer in
the field of digital dentistry, an expert in the development and performance
of dental materials and products, and a global thought leader in dental
education. We look forward to benefitting from her unique perspective and
strategic insights, as Henry Schein continues to focus on providing digital
dental solutions to our customers around the world."

Dr. Rekow has a long and distinguished career in dentistry, including a decade
as a Professor of Orthodontics at New York University, as well as senior roles
at multiple dental and scientific associations. An internationally recognized
authority on the performance of new materials and products for use in
aesthetic and restorative dentistry, Dr. Rekow has been a leader in research
on the use of bio-engineered tissue to facilitate bone replacement in
individuals who have been disfigured by disease or developmental defects as
well as research in elucidating damage initiation and propagation in brittle
materials. Dr. Rekow also holds a number of patents in the dental field and is
the author of, or contributor to, more than one hundred publications.

"It is a pleasure to join the Board of a company that is committed to
technology leadership in all facets of its business," said Dr. Rekow. "Not
only has Henry Schein been a pioneer in meeting the needs of its dental,
animal health and medical customers for decades, but through its continual
reinvention of the organization, Henry Schein has also helped recreate and
advance the markets that it serves. I look forward to being part of such a
future-focused company and to helping Henry Schein sustain the admirable
leadership role it has forged." 

Prior to joining Kings College, Dr. Rekow was a Professor of Orthodontics at
New York University (NYU) from 2002 to 2012, also serving as Senior Vice
Provost of Engineering Technology at NYU from 2008 to 2012, and, as Provost of
Polytechnic Institute of NYU from 2009 to 2012. Dr. Rekow has served as
President of the International Association for Dental Research (IADR) and the
American Association of Dental Research (AADR), and since 2000 she has been an
American Dental Association Consultant to the Council on Scientific Affairs.
In 2011, Dr. Rekow was elected to the Faculty of Dental Surgery of the Royal
College of Surgeons of England.

About Henry Schein, Inc.
Henry Schein, Inc.is the world's largest provider of health care products and
services to office-based dental, animal health and medical practitioners. The
Company also serves dental laboratories, government and institutional health
care clinics, and other alternate care sites. A Fortune 500® Company and a
member of the NASDAQ 100® Index, Henry Schein employs nearly 17,000 Team
Schein Members and serves more than 800,000 customers.

The Company offers a comprehensive selection of products and services,
including value-added solutions for operating efficient practices and
delivering high-quality care. Henry Schein operates through a centralized and
automated distribution network, with a selection of more than 96,000 branded
products and Henry Schein private-brand products in stock, as well as more
than 110,000 additional products available as special-order items. The
Company also offers its customers exclusive, innovative technology solutions,
including practice management software and e-commerce solutions, as well as a
broad range of financial services.

Headquartered inMelville, N.Y., Henry Schein has operations or affiliates in
27 countries. The Company's sales reached a record$9.6 billionin 2013, and
have grown at a compound annual rate of approximately 16 percent since Henry
Schein became a public company in 1995. For more information, visit the Henry
Schein website atwww.henryschein.com.

Photo - http://photos.prnewswire.com/prnh/20140603/93866

SOURCE Henry Schein, Inc.

Website: http://www.henryschein.com
Contact: Investors, Steven Paladino, Executive Vice President and Chief
Financial Officer, steven.paladino@henryschein.com, (631) 843-5500, Carolynne
Borders, Vice President, Investor Relations,
carolynne.borders@henryschein.com, (631) 390-8105, Media, Susan Vassallo, Vice
President, Corporate Communications, susan.vassallo@henryschein.com, (631)
Press spacebar to pause and continue. Press esc to stop.